The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Guangzhou, Guangdong, 510120, China
Location status: Recruiting
NCT Number: NCT06268236
With the rapid development of life support technology, more and more people can survive severe brain injury. Some survivors regain consciousness after a period of coma, however, many patients develop prolonged disorders of consciousness (DOC), which poses a therapeutic challenge for clinicians and a heavy burden for their families. The investigators design an Electro-acupuncture to treat disorder of consciousness (AcuDoc) trial with the aim of validating the clinical effect of electroacupuncture in treating DOC and exploring its therapeutic mechanisms by integrating EEG, neuroimaging, evoked potential tests, and behavioral assessments.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Guangzhou, Guangdong, 510120, China
Location status: Recruiting
The AcuDoc trial is a single-center, prospective, triple masking, randomized, sham electroacupuncture-controlled study. A total of 50 adult patients with DOC and 25 healthy subjects will be enrolled in the study . Patients will be randomized into electroacupuncture (EA) group or sham EA group (1:1). All patients will receive EA or sham-EA treatment in the supine position at 9 am for 30 minutes once a day for consecutive 14 days and healthy subjects will receive no treatments. The primary objective is to determine the therapeutic benefit of electroacupuncture on the recovery of consciousness in patients with DOC after a 2-week intervention. Key secondary objective is to investigate the effect of electroacupuncture on the circuitry of consciousness using a multimodal approach integrating EEG, neuroimaging (rs-fMRI, amide proton transfer imaging, intravoxel incoherent motion imaging, neurite orientation dispersion and density imaging), and evoked potentials (SEP, BAEP). Other secondary outcomes include the effect of EA on the assessment of brain-computer interface after a 2-week intervention and on the Glasgow Outcome Scale-Extended score at 30 days and 90 days .
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Electro-acupuncture at Shuigou and Yintang.
Sham-EA at sham-Shuigou and sham-Yintang.
Time frame: after 14 days of EA or sham-EA treatment
0 - 23, a higher score indicates a better level of consciousness
Time frame: after 14 days of EA or sham-EA treatment
measured by electroencephalogram
Time frame: after 14 days of EA or sham-EA treatment
measured by resting-state functional magnetic resonance imaging
Time frame: after 14 days of EA or sham-EA treatment
measured by amide proton transfer imaging
Time frame: after 14 days of EA or sham-EA treatment
measured by intravoxel incoherent motion imaging
Time frame: after 14 days of EA or sham-EA treatment
measured by neurite orientation dispersion and density imaging
Time frame: after 14 days of EA or sham-EA treatment
measured by somatosensory evoked potential biomarkers
Time frame: after 14 days of EA or sham-EA treatment
measured by brainstem auditory evoked potential
Time frame: 30 days after randomization
1 - 8, a higher score indicates better functional recovery from brain injury
Time frame: 90 days after randomization
1 - 8, a higher score indicates better functional recovery from brain injury
Time frame: after 14 days of EA or sham-EA treatment
measured by electroencephalogram-based brain-computer interface experiment
Contact information is provided by the study sponsor or research team.
Fang Yuan, PhD
CONTACT
Jixiang Chen, PhD
CONTACT
The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06469983
Acquired Brain Injury, Brain Diseases
Sant'Angelo dei Lombardi, Avellino, Italy
View Trial DetailsNCT06635291
Acquired Brain Injury, Brain Diseases
Bosisio Parini, Lecco, Italy
View Trial DetailsNCT07209657
Acquired Brain Injury, Brain Diseases
Parkville, Victoria, Australia
View Trial DetailsNCT07455682
Brain Damage, Chronic, Brain Diseases
Hessisch Oldendorf, Lower Saxony, Germany
View Trial Details